MHLW Approves Asahi Kasei’s Recomodulin Among Others
This article was originally published in PharmAsia News
Executive Summary
Among drugs approved by Japan's Ministry of Health, Labor and Welfare on Jan. 25 is Asahi Kasei Pharma's Recomodulin (recombinant thrombomodulin), the world's first recombinant thrombomodulin drug for treatment of disseminated intravascular coagulation. Other notables are Bayer's kidney cancer drug Nexavar and Zevalin Yttrium IV Set, a monoclonal antibody combined with radioisotope Yttrium, also developed by Bayer